Cardiovascular Diseases Research in Massachusetts
Cardiovascular Diseases Research (93.837) awarded $1.5 billion to recipients in Massachusetts in 1,120 grants from fiscal 2021 to 2025, 10% of the program's national total. Brigham & Womens Hospital Inc received the most, $374 million.
- Awarded in Massachusetts$1.5 billion
- Awards1,120
- Share of the program10%
- Rank among states2nd of 51
- National total$15 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 547 | $281 million |
| FY 2022 | 562 | $283 million |
| FY 2023 | 580 | $313 million |
| FY 2024 | 578 | $314 million |
| FY 2025 | 571 | $323 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Brigham & Womens Hospital Inc | Nonprofits | 274 | $374 million |
| The General Hospital Corporation | Nonprofits | 191 | $277 million |
| The Children's Hospital Corporation | Nonprofits | 130 | $204 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 81 | $139 million |
| University of Massachusetts Medical School | Colleges and universities | 54 | $98.9 million |
| Trustees of Boston University | Colleges and universities | 84 | $96.2 million |
| President and Fellows of Harvard College | Colleges and universities | 33 | $60.0 million |
| Tufts Medical Center Parent, Inc. | Nonprofits | 23 | $33.4 million |
| President and Fellows of Harvard College | Colleges and universities | 37 | $24.9 million |
| Dana-Farber Cancer Institute, Inc. | Nonprofits | 13 | $22.5 million |
Open opportunities under this program
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 81 on the program page
Questions people ask
How much Cardiovascular Diseases Research money goes to Massachusetts?
$1.5 billion from fiscal 2021 to 2025, across 1,120 awards. Massachusetts ranks 2nd of 51 states and territories for this program.
Who receives Cardiovascular Diseases Research money in Massachusetts?
The largest recipient is Brigham & Womens Hospital Inc, with $374 million in 274 awards. Next are The General Hospital Corporation and The Children's Hospital Corporation.
Can organizations in Massachusetts apply now?
Yes, 81 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cardiovascular Diseases Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Allergy and Infectious Diseases Research
- Aging Research